241 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BOVN.F

BioInvent International
kr4.700%n/akr2.7bkr12.58PS9.2xE62.0%n/a

0RV2

BioArctic
kr223.006.2%-31.2%kr19.7bkr366.20PS78.1xE63.0%0%

IDD

Innate Pharma
€2.5714.2%-3.2%€206.6m€6.31PS3.4xE33.0%n/a

S1GE34

Seagen
US$56.706.7%n/aUS$43.2bUS$56.74PS18.8xE71.8%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

0A8R

Seagen
US$228.954.6%81.1%US$43.2bUS$229.12PS18.8xE71.8%n/a

IMGN *

ImmunoGen
US$268.500%96.1%US$8.4bUS$248.87PS29.1xE45.2%n/a

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

A196170

ALTEOGEN
₩189,400.008.5%285.0%₩10.0t₩220,000.00PS104xE124.4%n/a

41X

Ardelyx
US$7.13-3.2%108.5%US$1.9bUS$12.77PS11.4xE60.7%n/a

SPAGO

Spago Nanomedical
kr0.24-10.9%-68.9%kr55.1mn/aPS9.3xE52.1%n/a

IPHY.F

Innate Pharma
€2.200%n/a€206.6m€5.40PS3.4xE33.0%n/a

IVVD

Invivyd
US$2.21-10.2%33.9%US$263.5mUS$9.23PB1.5xE69.8%n/a

0A8K

ImmunoGen
US$31.246.4%658.3%US$8.4bUS$29.16PS29.1xE45.9%n/a

XBRANE BTU

Xbrane Biopharma
kr11.60-8.7%n/akr14.8mkr1,431.06PB0.09xE126.0%n/a

IMU

ImmunoGen
US$28.746.8%615.5%US$8.4bUS$26.83PS29.1xE45.9%n/a

ARDX *

Ardelyx
US$113.800%n/aUS$1.9bUS$198.45PS11.7xE60.7%n/a

0EVI

Innate Pharma
€2.539.4%-6.5%€206.6m€6.21PS3.4xE33.0%n/a

BIOA B

BioArctic
kr223.006.1%-31.5%kr19.7bkr366.20PS78.1xE63.0%0%

7UX

Spago Nanomedical
kr0.018-12.5%-72.0%kr55.1mn/aPS9.3xE52.1%n/a

IDDA

Innate Pharma
€2.409.1%-4.0%€206.6m€5.89PS3.4xE33.0%n/a

ARDX

Ardelyx
US$7.72-1.7%119.9%US$1.8bUS$13.83PS11.4xE60.7%n/a

MIRM *

Mirum Pharmaceuticals
US$479.150%n/aUS$1.2bUS$894.07PS6.6xE63.2%n/a

BRCT.F

BioArctic
kr21.7014.9%n/akr19.7bkr33.90PS82.1xE63.0%0%
Page 1 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.